Usp14 inhibitors (Proteostasis/Biogen)

N/A

Report date: 2025/03/20 09:46:09
NME

Base Information

Drug NameUsp14 inhibitors (Proteostasis/Biogen)
Drug Alias NameUsp14 inhibitors (Proteostasis Therapeutics)PTi-HUsp14 inhibitors (Proteostasis/Biogen Idec)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUbiquitin specific peptidase 14 inhibitors
TargetsUbiquitin specific peptidase 14
Therapy Area/IndicationsNerve Degeneration
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesHarvard University
China Registration ClassN/A

Develop Information

Active CompaniesProteostasis Therapeutics IncBiogen Inc
Inactive CompaniesN/A
Active IndicationsNerve Degeneration
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A